Acryl
Financials
Valuation Metrics
Acryl's Market Cap is ₩1597B. Ranked #994 of 2,421 in KR market (top 41%), #497 of 1,640 on KOSDAQ (top 30%), #28 of 159 in Software & Services (top 18%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 159.72B KRW | KR#994/2,421 Sec#28/159 |
| Revenue | 13.31B KRW | KR#2,240/2,421 Sec#142/159 |
| Net Income | -2.81B KRW | KR—/2,421 Sec—/159 |
| Total Assets | 50.94B KRW | KR#2,201/2,421 Sec#120/159 |
| Net Assets | 43.75B KRW | KR#1,994/2,421 Sec#103/159 |
| Value | ||
| P/B | 3.65x | KR#2,166/2,421 Sec#145/159 |
| P/S | 12.00x | KR#2,292/2,421 Sec#155/159 |
| FCF Yield | -3.67% | KR—/2,421 Sec—/159 |
| Profitability | ||
| ROE | -6.42% | KR#1,843/2,421 Sec#117/159 |
| ROA | -5.51% | KR#1,954/2,421 Sec#125/159 |
| Op. Margin | -16.93% | KR#2,090/2,421 Sec#134/159 |
| Financial Health | ||
| Debt Ratio | 16.43% | KR#285/2,421 Sec#28/159 |
| FCF | -5.86B KRW | KR#1,534/2,421 Sec#116/159 |
| Cash | 41.39B KRW | KR#831/2,421 Sec#29/159 |
| Current Ratio | 7.79x | KR#150/2,421 Sec#16/159 |
| Performance | ||
| 1M Return | 20.69% | KR#229/2,421 Sec#24/159 |
| From 52W High | -74.17% | KR#2,274/2,421 Sec#150/159 |
| 1Y MDD | -80.30% | KR#2,300/2,421 Sec#149/159 |
| Trading | ||
| Volume | 316,790 shares | KR#343/2,421 Sec#22/159 |
| Trading Value | 6.48B KRW | KR#320/2,421 Sec#9/159 |
| Foreign Own. | 5.40% | KR#807/2,421 Sec#30/159 |
| Per Share | ||
| EPS | -350 KRW | KR—/2,421 Sec—/159 |
| BPS | 5,448 KRW | KR#1,431/2,421 Sec#62/159 |
Company Info
Acryl, established in 2011 and headquartered in Gangnam-gu, Seoul Metropolitan City, is an AI eXperience (AX) infrastructure specialist. The company supports the entire process from AI service construction to infrastructure operation, leveraging AI infrastructure technology. It develops NLP-related deep learning original technology for high-performance emotional recognition and creates software services to effectively deliver artificial intelligence. Its product lines include the integrated artificial intelligence platform 'Jonathan' and the medical-specialized artificial intelligence platform 'Nadia'.